O

Olema Oncology

20 employees

Olema Oncology is a preclinical biotechnology company that develops new drugs for the treatment and prevention of breast cancer.

Basic info

Industry

biotechnology

Sectors

Biotechnology
biotechnology
drug development
breast cancer
Pharmaceutical
pharmaceuticals
oncology
nuclear receptors
Health Care
Medical
Biopharma
small molecules

Date founded

2007

Funding rounds raised

Total raised

$130M

from 18 investors over 18 rounds

O

Olema Oncology raised $130M on September 5, 2023

Investors: Logos Global Management, LP, Vivo Capital, Lightspeed Venture Partners and Woodline Partners LP

O

Olema Oncology raised $85M on October 1, 2020

Investors: RA Capital Management, L.P., Wellington Management, Foresite Capital, Logos Global Management, LP, OrbiMed Advisors, Venrock, Vivo Capital and Surveyor Capital

O

Olema Oncology raised $54M on July 22, 2020

Investors: Wellington Management, Venrock, RA Capital Management, L.P., Logos Global Management, LP, Foresite Capital and Surveyor Capital

FAQ